Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Marieke J H A Kruip"'
Autor:
Jetske Graafsma, Joanna E Klopotowska, Hieronymus J Derijks, Ewoudt M W van de Garde, Rien H L Hoge, Marieke J H A Kruip, Karina Meijer, Fatma Karapinar-Carkit, Patricia M L A van den Bemt
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0306033 (2024)
Antithrombotics require careful monitoring to prevent adverse events. Safe use can be promoted through so-called antithrombotic stewardship. Clinical decision support systems (CDSSs) can be used to monitor safe use of antithrombotics, supporting anti
Externí odkaz:
https://doaj.org/article/fb72e9f2b4574e468baef9ed9a092c6d
Autor:
Albert R Dreijer, Marieke J H A Kruip, Jeroen Diepstraten, Suzanne Polinder, Rolf Brouwer, Peter G M Mol, F Nanne Croles, Esther Kragten, Frank W G Leebeek, Patricia M L A van den Bemt
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0235048 (2020)
BackgroundAlthough the benefits of antithrombotic drugs are indisputable to reduce thrombotic events, they carry a high risk of compromising patient safety. No previous studies investigated the implementation and (cost-) effectiveness of a hospital-b
Externí odkaz:
https://doaj.org/article/716e728dc4324b44912122915fb43a28
Autor:
Janine E van Loon, Yvonne V Sanders, Eva M de Wee, Marieke J H A Kruip, Moniek P M de Maat, Frank W G Leebeek
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40624 (2012)
BACKGROUND: In type 1 von Willebrand Disease (VWD) patients, von Willebrand Factor (VWF) levels and bleeding symptoms are highly variable. Recently, the association between genetic variations in STXBP5 and STX2 with VWF levels has been discovered in
Externí odkaz:
https://doaj.org/article/e2972f4d8fc64a35b495456d39964aca
Autor:
Johanna Louise I. Burggraaf, Sanne Bakker, Marieke J. H. A. Kruip, Felix J. M. van der Meer, Willem M. Lijfering, Nienke van Rein
Publikováno v:
Thrombosis and Haemostasis, 123(2), 245-254. Georg Thieme Verlag
Background Selective serotonin reuptake inhibitors (SSRIs) may increase the risk of major bleeding by decreasing platelet function or decreasing vitamin K antagonist (VKA) metabolism via cytochrome P450 (CYP) inhibition. Aims To determine whether SSR
Autor:
Jeroen Diepstraten, Anne van Rongen, Marianne P. Zijlstra, Marieke J. H. A. Kruip, Pim L. J. van der Heiden, Rob ter Heine
Publikováno v:
Clinical Pharmacokinetics, 62(2), 297-305. Adis
Clinical Pharmacokinetics, 62, 2, pp. 297-305
Clinical Pharmacokinetics, 62, 297-305
Clinical Pharmacokinetics, 62, 2, pp. 297-305
Clinical Pharmacokinetics, 62, 297-305
Item does not contain fulltext BACKGROUND AND OBJECTIVE: Low-molecular-weight heparins are routinely administered to patients in the intensive care unit to prevent venous thromboembolisms. There is considerable evidence that low-molecular-weight hepa
Autor:
Lorenzo G. R. Romano, Nicole G. M. Hunfeld, Marieke J. H. A. Kruip, Henrik Endeman, Tim Preijers
Publikováno v:
British Journal of Clinical Pharmacology, 89(5), 1617-1628. Wiley-Blackwell Publishing Ltd
Aims: Nadroparin is administered to COVID-19 intensive care unit (ICU) patients as thromboprophylaxis. Despite existing population pharmacokinetic (PK) models for nadroparin in literature, the population PK of nadroparin in COVID-19 ICU patients is u
Autor:
Adrian Scutelnic, Katarzyna Krzywicka, Joshua Mbroh, Anita van de Munckhof, Mayte Sánchez van Kammen, Diana Aguiar de Sousa, Erik Lindgren, Katarina Jood, Albrecht Günther, Sini Hiltunen, Jukka Putaala, Andreas Tiede, Frank Maier, Rolf Kern, Thorsten Bartsch, Katharina Althaus, Alfonso Ciccone, Markus Wiedmann, Mona Skjelland, Antonio Medina, Elisa Cuadrado‐Godia, Thomas Cox, Avinash Aujayeb, Nicolas Raposo, Katia Garambois, Jean‐Francois Payen, Fabrice Vuillier, Guillaume Franchineau, Serge Timsit, David Bougon, Marie‐Cécile Dubois, Audrey Tawa, Clement Tracol, Emmanuel De Maistre, Fabrice Bonneville, Caroline Vayne, Annerose Mengel, Dominik Michalski, Johann Pelz, Matthias Wittstock, Felix Bode, Julian Zimmermann, Judith Schouten, Alina Buture, Sean Murphy, Vincenzo Palma, Alberto Negro, Alexander Gutschalk, Simon Nagel, Silvia Schoenenberger, Giovanni Frisullo, Carla Zanferrari, Francesco Grillo, Fabrizio Giammello, Mar Morin Martin, Alvaro Cervera, Jim Burrow, Carlos Garcia Esperon, Beng Lim Alvin Chew, Timothy J. Kleinig, Cristina Soriano, Domenico S. Zimatore, Marco Petruzzellis, Ahmed Elkady, Miguel S. Miranda, João Fernandes, Åslög Hellström Vogel, Elias Johansson, Anemon Puthuppallil Philip, Shelagh B. Coutts, Simerpreet Bal, Brian Buck, Catherine Legault, Dylan Blacquiere, Hans D. Katzberg, Thalia S. Field, Vanessa Dizonno, Thomas Gattringer, Christian Jacobi, Annemie Devroye, Robin Lemmens, Espen Saxhaug Kristoffersen, Monica Bandettini di Poggio, Masoud Ghiasian, Theodoros Karapanayiotides, Sophie Chatterton, Miriam Wronski, Karl Ng, Robert Kahnis, Thomas Geeraerts, Peggy Reiner, Charlotte Cordonnier, Saskia Middeldorp, Marcel Levi, Eric C. M. van Gorp, Diederik van de Beek, Justine Brodard, Johanna A. Kremer Hovinga, Marieke J. H. A. Kruip, Turgut Tatlisumak, José M. Ferro, Jonathan M. Coutinho, Marcel Arnold, Sven Poli, Mirjam R. Heldner
Publikováno v:
Annals of Neurology, 92, 562-573
Annals of Neurology, 92(4), 562-573. John Wiley & Sons Inc.
Scutelnic, Adrian; Krzywicka, Katarzyna; Mbroh, Joshua; van de Munckhof, Anita; Sánchez van Kammen, Mayte; Aguiar de Sousa, Diana; Lindgren, Erik; Jood, Katarina; Günther, Albrecht; Hiltunen, Sini; Putaala, Jukka; Tiede, Andreas; Maier, Frank; Kern, Rolf; Bartsch, Thorsten; Althaus, Katharina; Ciccone, Alfonso; Wiedmann, Markus; Skjelland, Mona; Medina, Antonio; ... (2022). Management of cerebral venous thrombosis due to adenoviral COVID-19 vaccination. Annals of neurology, 92(4), pp. 562-573. Wiley-Blackwell 10.1002/ana.26431
Annals of neurology, 92(4), 562-573. John Wiley and Sons Inc.
Annals of Neurology, 92, 4, pp. 562-573
Annals of Neurology, 92(4), 562-573. John Wiley & Sons Inc.
Scutelnic, Adrian; Krzywicka, Katarzyna; Mbroh, Joshua; van de Munckhof, Anita; Sánchez van Kammen, Mayte; Aguiar de Sousa, Diana; Lindgren, Erik; Jood, Katarina; Günther, Albrecht; Hiltunen, Sini; Putaala, Jukka; Tiede, Andreas; Maier, Frank; Kern, Rolf; Bartsch, Thorsten; Althaus, Katharina; Ciccone, Alfonso; Wiedmann, Markus; Skjelland, Mona; Medina, Antonio; ... (2022). Management of cerebral venous thrombosis due to adenoviral COVID-19 vaccination. Annals of neurology, 92(4), pp. 562-573. Wiley-Blackwell 10.1002/ana.26431
Annals of neurology, 92(4), 562-573. John Wiley and Sons Inc.
Annals of Neurology, 92, 4, pp. 562-573
© 2022 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.562 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which pe
Autor:
Felix J. M. van der Meer, Melchior C Nierman, Laura M. Faber, Marieke J. H. A. Kruip, Myrthe M A Toorop, Suzanne C. Cannegieter, Qingui Chen, Lies Goede, Willem M. Lijfering
Publikováno v:
Journal of Thrombosis and Haemostasis. WILEY
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, 20(2), 339-352. WILEY
Journal of Thrombosis and Haemostasis, 20(2), 339-352. Wiley-Blackwell Publishing Ltd
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, 20(2), 339-352. WILEY
Journal of Thrombosis and Haemostasis, 20(2), 339-352. Wiley-Blackwell Publishing Ltd
Background: Non-valvular atrial fibrillation (NVAF) patients are advised to switch from a vitamin K antagonist (VKA) to direct oral anticoagulant (DOAC) when time in therapeutic range (TTR) is low. Objective: To examine if pre-switch TTR determines p
Autor:
Jes S. Lindholt, Florian K. Enzmann, Niels Bækgaard, Beverley J. Hunt, Gerard Stansby, Nabil Chakfe, Stavros K. Kakkos, Ismail Elalamy, Marieke J. H. A. Kruip, Stephen A. Black, Rupert Bauersachs, Philippe Kolh, Manjit Gohel, Armando Mansilha, Manuel Monreal, Igor Koncar, Riikka Tulamo, Frederico Bastos Gonçalves, Per Morten Sandset, Anthony J. Comerota, Gert J. de Borst, Arina J. ten Cate-Hoek, Peter Gloviczki, Paolo Prandoni, Robert J. Hinchliffe, Christopher P. Twine, Frank Vermassen, Anders Wanhainen, Melina Vega de Ceniga, Anders Gottsäter, Marianne G. De Maeseneer, George Geroulakos, Sergi Bellmunt-Montoya, Andrew N. Nicolaides
Publikováno v:
European Journal of Vascular and Endovascular Surgery, 61(1), 9-82. W.B. Saunders
European Journal of Vascular and Endovascular Surgery, 61(1), 9-82. Elsevier Saunders
European Journal of Vascular and Endovascular Surgery, 61(1), 9-82. Elsevier Saunders
European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
Autor:
Barbara A. Hutten, Michiel Coppens, Roisin Bavalia, Ludo F. M. Beenen, Marieke J. H. A. Kruip, Saskia Middeldorp, Rahat A. Abdoellakhan, Hugo ten Cate, Marjolein P. A. Brekelmans, Karina Meijer, Renske H. Olie, Menno V. Huisman
Publikováno v:
Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis, 196, 404-409. PERGAMON-ELSEVIER SCIENCE LTD
Thrombosis research, 196, 404-409. Elsevier Limited
Thrombosis Research, 196, 404-409. Elsevier Science
Thrombosis Research, 196, 404-409. PERGAMON-ELSEVIER SCIENCE LTD
Thrombosis Research, 196, 404-409. Elsevier Ltd.
Thrombosis research, 196, 404-409. Elsevier Limited
Thrombosis Research, 196, 404-409. Elsevier Science
Thrombosis Research, 196, 404-409. PERGAMON-ELSEVIER SCIENCE LTD
Thrombosis Research, 196, 404-409. Elsevier Ltd.
Intracranial hemorrhage (ICH) is the most feared complication of anticoagulation with a high mortality and morbidity. Before registration of a specific reversal agent for factor Xa inhibitors (FXa-I), international guidelines recommended prothrombin